Evidence map›Paper›PMID 31788127›Full record

ArticleOncology letters2019

hsa_circRNA_100873 upregulation is associated with increased lymphatic metastasis of esophageal squamous cell carcinoma.

Bin Zheng, Zhigang Wu, Songtao Xue, Hao Chen, Shuliang Zhang, Taidui Zeng, Guobing Xu, Weidong Wu, Wei Zheng, Chun Chen

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Circular RNAs and esophageal cancer.Cancer cell international · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Bin ZhengThoracic Department, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China.
Zhigang WuThoracic Department, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China.
Songtao XueThoracic Department, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China.
Hao ChenThoracic Department, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China.
Shuliang ZhangThoracic Department, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China.
Taidui ZengThoracic Department, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China.
Guobing XuThoracic Department, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China.
Weidong WuThoracic Department, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China.
Wei ZhengThoracic Department, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China.
Chun ChenThoracic Department, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China.
Fujian Medical University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are a type of endogenous non-coding RNA with multiple binding sites that specifically bind to microRNAs (miRNAs) and serve an important role in cellular regulatory networks. Patients exhibit varying levels of lymphatic metastasis in a clinical setting. The present study investigated the association between circRNAs and lymphatic metastasis in esophageal squamous cell carcinoma (ESCC). The tissue samples were divided into three groups, including early tumor stage associated with advanced nodal stage (T1 group), advanced tumor stage associated with early nodal stage (T2 group) and healthy esophageal epithelial tissues as the control group (C group). Gene chip analysis identified circRNAs, and those with possible regulatory functions were validated by reverse transcription-quantitative polymerase chain reaction analysis (RT-qPCR). circRNAs containing miRNA response element (MRE) sequences were obtained, and circRNA/miRNA prediction software was used to predict miRNAs that may interact with circRNA. A total of 12,275 circRNAs were detected, including 861 with statistically significant differences. A comparison between the T1 and C groups identified 152 upregulated circRNAs and 431 downregulated ones, while a comparison between the T2 and C groups identified 187 upregulated and 481 downregulated circRNAs. A T1/T2 group comparison revealed that four circRNAs were upregulated and seven were downregulated (fold change >1.5; P<0.05). The RT-qPCR data and gene chip analysis consistently identified hsa_circRNA_100873 as differentially expressed among the examined groups. A total of five potential MREs and complementary sequences were selected for hsa_circRNA_100873. The results of the present study indicated that multiple differentially expressed circRNAs are involved in the pathogenesis of ESCC, and that upregulation of hsa_circRNA_100873 may be associated with increased lymphatic metastases in ESCC.

Indexed as

circular RNAesophageal squamous cell carcinomaexpressionhsa_circRNA_100873lymphatic metastasis

Identifiers

PMID31788127
PMCPMC6865678
OpenAlexW2981160996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.